ATE267629T1 - Verwendung von carbamat verbindungen zur vorbeugung oder behandlung von neuropathischen- , cluster- und migräneartigen kopfschmerzen - Google Patents

Verwendung von carbamat verbindungen zur vorbeugung oder behandlung von neuropathischen- , cluster- und migräneartigen kopfschmerzen

Info

Publication number
ATE267629T1
ATE267629T1 AT01952773T AT01952773T ATE267629T1 AT E267629 T1 ATE267629 T1 AT E267629T1 AT 01952773 T AT01952773 T AT 01952773T AT 01952773 T AT01952773 T AT 01952773T AT E267629 T1 ATE267629 T1 AT E267629T1
Authority
AT
Austria
Prior art keywords
cluster
migraine
phenyl
alkyl
carbamat
Prior art date
Application number
AT01952773T
Other languages
English (en)
Inventor
Ellen E Codd
Richard P Shank
Katherine E Rogers
Carlos R Plata-Salaman
Boyu Zhao
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22820176&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE267629(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE267629T1 publication Critical patent/ATE267629T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01952773T 2000-07-21 2001-07-16 Verwendung von carbamat verbindungen zur vorbeugung oder behandlung von neuropathischen- , cluster- und migräneartigen kopfschmerzen ATE267629T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21965700P 2000-07-21 2000-07-21
PCT/US2001/022322 WO2002007822A2 (en) 2000-07-21 2001-07-16 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Publications (1)

Publication Number Publication Date
ATE267629T1 true ATE267629T1 (de) 2004-06-15

Family

ID=22820176

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01952773T ATE267629T1 (de) 2000-07-21 2001-07-16 Verwendung von carbamat verbindungen zur vorbeugung oder behandlung von neuropathischen- , cluster- und migräneartigen kopfschmerzen

Country Status (28)

Country Link
US (4) US20020107283A1 (de)
EP (1) EP1305082B1 (de)
JP (1) JP5271473B2 (de)
KR (1) KR100792814B1 (de)
CN (1) CN1250213C (de)
AT (1) ATE267629T1 (de)
AU (2) AU2001273493B2 (de)
BG (1) BG107529A (de)
BR (1) BR0112713A (de)
CA (1) CA2416819C (de)
CZ (1) CZ2003445A3 (de)
DE (1) DE60103546T2 (de)
DK (1) DK1305082T3 (de)
EA (1) EA005648B1 (de)
ES (1) ES2221651T3 (de)
HU (1) HUP0302940A3 (de)
IL (2) IL154052A0 (de)
MX (1) MXPA03000619A (de)
MY (1) MY127317A (de)
NO (1) NO330055B1 (de)
NZ (1) NZ523851A (de)
PL (1) PL365701A1 (de)
PT (1) PT1305082E (de)
SK (1) SK1962003A3 (de)
TR (1) TR200401511T4 (de)
UA (1) UA74195C2 (de)
WO (1) WO2002007822A2 (de)
ZA (1) ZA200301403B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60238765D1 (de) * 2001-02-27 2011-02-10 Ortho Mcneil Pharm Inc Carbamatverbindungen zur behandlung von schmerz
PT1408954E (pt) 2001-07-16 2009-07-28 Ortho Mcneil Janssen Pharm Compostos carbamatos para utilização na prevenção ou tratamento da dor neuropática
CN101669933A (zh) * 2001-07-16 2010-03-17 奥索-麦克尼尔药品公司 用于预防或治疗神经性疼痛和丛集性头痛及偏头痛性疼痛的氨基甲酸酯化合物
US20040087642A1 (en) * 2002-10-24 2004-05-06 Zeldis Jerome B. Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
US7323443B2 (en) * 2002-12-12 2008-01-29 Agennix Inc. Lactoferrin in the reduction of pain
US7183381B2 (en) * 2004-10-26 2007-02-27 Agennix, Inc. Composition of lactoferrin related peptides and uses thereof
JP2008528489A (ja) * 2005-01-20 2008-07-31 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｑｔ間隔調節方法
EP1998802A2 (de) 2006-03-30 2008-12-10 GlaxoSmithKline Biologicals S.A. Immunogene zusammensetzung
KR20090082209A (ko) * 2006-10-10 2009-07-29 얀센 파마슈티카 엔.브이. 신규 (ｓ)-(＋)-2-(2-클로로페닐)-2-하이드록시-에틸 카바메이트 결정
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US20150057351A1 (en) * 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
HU191549B (en) * 1984-04-11 1987-03-30 Richter Gedeon Vegyeszet Process for producing 1-/6-/2 comma above-substituted-5 comma above, 6 comma above, 7 comma above, 8 comma above-tetrahydro-4 comma above-oxo-quinazolino//-3,4-dihydro-6,7-disubstituted-isoquinoline derivatives
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines
GB9518027D0 (en) * 1995-09-05 1995-11-08 Wellcome Found Pharmacologically active compound
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
IL133242A0 (en) * 1997-06-05 2001-03-19 Sanofi Synthelabo 5-Naphthalene-1-yl-1,3-dioxane derivatives their preparation and their therapeutic application
CN1262272C (zh) * 2001-02-27 2006-07-05 奥索-麦克尼尔药品公司 用于预防或治疗运动障碍的氨基甲酸酯化合物
CZ302412B6 (cs) * 2001-02-27 2011-05-04 Ortho-Mcneil Pharmaceutical, Inc. Lécivo pro prevenci nebo lécbu psychotických chorob
CA2439475C (en) * 2001-02-27 2010-05-18 Carlos R. Plata-Salaman Carbamate compounds for use in preventing or treating bipolar disorder

Also Published As

Publication number Publication date
CA2416819A1 (en) 2002-01-31
EA200300042A1 (ru) 2003-06-26
CZ2003445A3 (cs) 2004-08-18
HUP0302940A2 (hu) 2003-12-29
ES2221651T3 (es) 2005-01-01
HUP0302940A3 (en) 2012-02-28
MY127317A (en) 2006-11-30
AU2001273493B2 (en) 2005-08-11
AU7349301A (en) 2002-02-05
EP1305082A2 (de) 2003-05-02
BR0112713A (pt) 2003-07-22
MXPA03000619A (es) 2004-07-30
DE60103546T2 (de) 2005-06-09
DE60103546D1 (de) 2004-07-01
US20020107283A1 (en) 2002-08-08
IL154052A0 (en) 2003-07-31
US20090281179A1 (en) 2009-11-12
JP5271473B2 (ja) 2013-08-21
UA74195C2 (uk) 2005-11-15
CN1250213C (zh) 2006-04-12
EP1305082B1 (de) 2004-05-26
BG107529A (bg) 2003-09-30
DK1305082T3 (da) 2004-09-13
JP2004504362A (ja) 2004-02-12
CA2416819C (en) 2011-03-22
KR100792814B1 (ko) 2008-01-14
NO330055B1 (no) 2011-02-14
CN1458853A (zh) 2003-11-26
NO20030299D0 (no) 2003-01-20
WO2002007822A2 (en) 2002-01-31
TR200401511T4 (tr) 2004-08-23
ZA200301403B (en) 2004-06-15
KR20030022300A (ko) 2003-03-15
PL365701A1 (en) 2005-01-10
US20060183795A1 (en) 2006-08-17
NO20030299L (no) 2003-03-12
WO2002007822A3 (en) 2002-05-30
US20040266866A1 (en) 2004-12-30
PT1305082E (pt) 2004-09-30
EA005648B1 (ru) 2005-04-28
IL154052A (en) 2008-07-08
SK1962003A3 (en) 2004-08-03
NZ523851A (en) 2004-09-24

Similar Documents

Publication Publication Date Title
YU67703A (sh) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
ATE378046T1 (de) Carbamatverbindungen zur vorbeugung oder behandlung bipolarer erkrankungen
ATE267629T1 (de) Verwendung von carbamat verbindungen zur vorbeugung oder behandlung von neuropathischen- , cluster- und migräneartigen kopfschmerzen
ATE324108T1 (de) Carbamatverbindungen zur verwendung bei der prävention oder behandlung der bipolaren erkrankung
ATE324107T1 (de) Carbamat-verbindungen zur prävention oder behandlung von angstzuständen
DE60232796D1 (de) Carbamate verbindungen zur vorbeugung oder behandlung von neuropathischen schmerzen
PL368112A1 (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY137446A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY136347A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1305082

Country of ref document: EP

REN Ceased due to non-payment of the annual fee